检验医学与临床
檢驗醫學與臨床
검험의학여림상
JOURNAL OF LABORATORY MEDICINE AND CLINICAL SCIENCES
2014年
12期
1595-1598
,共4页
赵连爽%代娣%陈昕%云科%王倩%WANG Qian
趙連爽%代娣%陳昕%雲科%王倩%WANG Qian
조련상%대제%진흔%운과%왕천%WANG Qian
基因芯片%分枝杆菌%鉴定%耐药
基因芯片%分枝桿菌%鑒定%耐藥
기인심편%분지간균%감정%내약
gene chip%mycobacterium tuberculosis%identification%drug resistance
目的:探讨基因芯片检测系统在分枝杆菌菌种鉴定及耐药基因检测中的临床应用价值。方法应用基因芯片技术对疑似结核病和非结核分枝杆菌病患者的痰液、尿液、胸腹腔积液、脑脊液和穿刺液等标本进行核酸检测;并对分枝杆菌阳性样本进行利福平及异烟肼的耐药基因检测。结果91例标本中共检出结核分枝杆菌复合群16例,非结核分枝杆菌2例(戈登分枝杆菌1例、偶然分枝杆菌1例),分枝杆菌检出总阳性率为19.8%(18/91),其中结核分枝杆菌占17.6%(16/91),非结核分枝杆菌占2.2%(2/91);不同标本类型检出阳性率有差别,由高到低依次为穿刺脓液(33.3%)、痰液(24.0%)、胸腹腔积液(18.8%)、脑脊液(16.7%)和尿液(15.8%)。有57例患者同时进行了基因芯片法和涂片抗酸染色法检测,其中芯片法有16例阳性,阳性率为28.1%(16/57),涂片法有3例阳性,阳性率为5.3%(3/57),两种方法比较,差异有统计学意义( P<0.01)。18例分枝杆菌阳性标本进一步进行耐药基因检测,有4例发生耐药基因突变,其中2例(1例戈登分枝杆菌)为利福平耐药相关基因,ro pB基因526位点发生C→G突变,1例为ropB基因531位点发生C→T突变,还有1例为异烟肼耐药相关基因,inhA基因启动子-15位点发生C→T突变;没有检测到多重耐药株。结论基因芯片技术适用于不同标本类型的分枝杆菌菌种鉴定及耐药基因检测,操作简便快速,灵敏度高,特异性好。
目的:探討基因芯片檢測繫統在分枝桿菌菌種鑒定及耐藥基因檢測中的臨床應用價值。方法應用基因芯片技術對疑似結覈病和非結覈分枝桿菌病患者的痰液、尿液、胸腹腔積液、腦脊液和穿刺液等標本進行覈痠檢測;併對分枝桿菌暘性樣本進行利福平及異煙肼的耐藥基因檢測。結果91例標本中共檢齣結覈分枝桿菌複閤群16例,非結覈分枝桿菌2例(戈登分枝桿菌1例、偶然分枝桿菌1例),分枝桿菌檢齣總暘性率為19.8%(18/91),其中結覈分枝桿菌佔17.6%(16/91),非結覈分枝桿菌佔2.2%(2/91);不同標本類型檢齣暘性率有差彆,由高到低依次為穿刺膿液(33.3%)、痰液(24.0%)、胸腹腔積液(18.8%)、腦脊液(16.7%)和尿液(15.8%)。有57例患者同時進行瞭基因芯片法和塗片抗痠染色法檢測,其中芯片法有16例暘性,暘性率為28.1%(16/57),塗片法有3例暘性,暘性率為5.3%(3/57),兩種方法比較,差異有統計學意義( P<0.01)。18例分枝桿菌暘性標本進一步進行耐藥基因檢測,有4例髮生耐藥基因突變,其中2例(1例戈登分枝桿菌)為利福平耐藥相關基因,ro pB基因526位點髮生C→G突變,1例為ropB基因531位點髮生C→T突變,還有1例為異煙肼耐藥相關基因,inhA基因啟動子-15位點髮生C→T突變;沒有檢測到多重耐藥株。結論基因芯片技術適用于不同標本類型的分枝桿菌菌種鑒定及耐藥基因檢測,操作簡便快速,靈敏度高,特異性好。
목적:탐토기인심편검측계통재분지간균균충감정급내약기인검측중적림상응용개치。방법응용기인심편기술대의사결핵병화비결핵분지간균병환자적담액、뇨액、흉복강적액、뇌척액화천자액등표본진행핵산검측;병대분지간균양성양본진행리복평급이연정적내약기인검측。결과91례표본중공검출결핵분지간균복합군16례,비결핵분지간균2례(과등분지간균1례、우연분지간균1례),분지간균검출총양성솔위19.8%(18/91),기중결핵분지간균점17.6%(16/91),비결핵분지간균점2.2%(2/91);불동표본류형검출양성솔유차별,유고도저의차위천자농액(33.3%)、담액(24.0%)、흉복강적액(18.8%)、뇌척액(16.7%)화뇨액(15.8%)。유57례환자동시진행료기인심편법화도편항산염색법검측,기중심편법유16례양성,양성솔위28.1%(16/57),도편법유3례양성,양성솔위5.3%(3/57),량충방법비교,차이유통계학의의( P<0.01)。18례분지간균양성표본진일보진행내약기인검측,유4례발생내약기인돌변,기중2례(1례과등분지간균)위리복평내약상관기인,ro pB기인526위점발생C→G돌변,1례위ropB기인531위점발생C→T돌변,환유1례위이연정내약상관기인,inhA기인계동자-15위점발생C→T돌변;몰유검측도다중내약주。결론기인심편기술괄용우불동표본류형적분지간균균충감정급내약기인검측,조작간편쾌속,령민도고,특이성호。
Objective To investigate the diagnostic value of gene chip in identification of mycobacterium and detection of drug-resistant genes .Methods Gene chip technology was used in DNA detection of sputum ,urine ,pleu-ral effusion ,cerebrospinal fluid ,and puncture fluid samples from suspected tuberculosis and nontuberculous mycobac-teria patients ,and positive samples of mycobacterium were detected for drug-resistant genes of mycobacterium to ri-fampin and isoniazid further .Results Among 91 samples detected ,16 cases of mycobacterium tuberculosis complex , 2 cases of nontuberculous mycobacteria (1 case of Gordon′s bacillus ,1 case of mycobacterium fortuitum ) ,the positive rate of mycobacterium was 19 .8% (18/91) ,which the mycobacterium tuberculosis accounted for 17 .6% (16/91);Mycobacterium non tuberculosis accounted for 2 .2% (2/91) .The positive rate of various types of samples were dif-ferent ,which puncture pus ,sputum ,pleural effusion ,cerebrospinal fluid and urine accounted for 33 .3% ,24% , 18 .8% ,16 .7% and 15 .8% .57 patients were detected by the gene chip method and mycobacterium smear acid-fast staining at the time ,the chip was positive in 16 cases ,the positive rate was 28 .1% (16/57) ,smear was positive in 3 cases ,the positive rate was 5 .3% (3/57) ,there was significant difference between the two methods (P<0 .01) .18 ca-ses of Mycobacterium positive samples were detected for drug-resistant genes further ,4 cases showed drug-resistant genes mutation ,2 cases(1 case Gordon mycobacteria) were ropB gene 526 C → G mutation ,1 case was ropB gene 531 C → T mutation ,1 case was InhA gene promoter-15 C → T mutation .Multiple resistant strains were not detected . Conclusion The gene chip technology can be used for mycobacterial species identification and drug-resistant genes detection In different types of samples ,which is simple and rapid in procedure and have high sensitivity and good spe-cificity .